Bromantane — Safety, Research, Risks & Legal Status

Not medical advice. Bromantane is discussed here for informational and harm-reduction purposes only. We do not endorse use, and any dosing context is informational, not a protocol.

Also known as	Ladasten, bromantane analogue, Adamax
Category	Research Chemical
russian_approval	Approved as Ladasten for psychostimulation in Russia and post-Soviet states
adamantane_family	Shares adamantane core structure with memantine and rimantadine
dopamine_focus	Primarily addresses dopaminergic deficit rather than serotonin
US legal status	Not FDA-approved in the US. Approved in Russia and some post-Soviet countries as a psychostimulant medication. Sold as a research chemical online; not federally scheduled but regulatory status is unclear in many jurisdictions.

What is Bromantane?

Bromantane is a synthetic adamantane-based compound developed in Russia as a psychostimulant and anxiolytic. Proposed mechanisms include dopamine and serotonin modulation, though the exact pharmacology remains unclear.

How it works

Dopamine and serotonin modulation via mechanisms not fully characterized. Theorized to enhance dopaminergic tone in reward and motivation circuits without direct reuptake inhibition.

Background & history

Developed in Russia in the 1980s and marketed as Ladasten for psychostimulation and mood support. Used clinically in post-Soviet countries for decades but remains largely unknown in Western medicine and research.

What the research says

Limited published research, mostly from Russian sources with variable methodological rigor. Some studies suggest mood elevation, improved cognitive performance, and reduced fatigue in small populations. Human evidence is sparse; animal studies show dopamine-enhancing effects.

Reported effects

Studied for psychostimulant properties and potential wakefulness promotion
Reported mood elevation and anxiolytic effects in Russian clinical trials
Reported improvements in reaction time and psychomotor performance
Reported fatigue reduction in small studies
Anecdotal reports of improved focus and motivation

Dosing & administration (informational)

Harm-reduction information only: Russian literature reports lower dose ranges than typical stimulants, though Western users often experiment with higher doses based on limited feedback.

This is general research/context information, not medical advice or a recommended protocol.

Safety & side effects

Limited long-term safety data; few adverse-event studies in humans
Potential for stimulant-related side effects (tachycardia, hypertension, anxiety, insomnia)
Quality and purity of research-chemical sources is highly variable
Unknown interaction profile with other medications and supplements
Contamination risk in unregulated supply chains

Drug & supplement interactions

Monoamine oxidase inhibitors (potential for hypertensive crisis)
Other stimulants and psychostimulants (additive cardiovascular effects)
Serotonergic agents (potential serotonin syndrome at high doses)
Antipsychotic medications (may counteract effects)

Who should avoid it

High-dose use without baseline cardiovascular assessment
Concurrent stimulant use (excessive tachycardia and hypertension risk)
Individuals with history of hypertension, arrhythmia, or cardiovascular disease
Evening use (insomnia and sleep disruption likely)
Abrupt cessation after chronic use (mood crash and fatigue)

How it is commonly combined

Combining with other stimulants or sympathomimetics increases cardiovascular stress and side-effect risk substantially.

Legal & regulatory. Not FDA-approved in the US. Approved in Russia and some post-Soviet countries as a psychostimulant medication. Sold as a research chemical online; not federally scheduled but regulatory status is unclear in many jurisdictions.

Quality & harm reduction

V
e
r
i
f
y
t
h
i
r
d
-
p
a
r
t
y
C
o
A
f
o
r
p
u
r
i
t
y
a
n
d
p
o
t
e
n
c
y
;
b
r
o
m
a
n
t
a
n
e
s
o
u
r
c
e
s
a
r
e
r
a
r
e
a
n
d
o
f
t
e
n
l
a
c
k
t
e
s
t
i
n
g
.
P
r
e
f
e
r
s
u
p
p
l
i
e
r
s
w
i
t
h
d
o
c
u
m
e
n
t
e
d
s
y
n
t
h
e
s
i
s
o
r
i
g
i
n
a
n
d
Q
A
p
r
o
c
e
d
u
r
e
s
.

Lab testing & harm-reduction tools

If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.

Compare testing options

Frequently asked questions

Where is bromantane legally available?

Bromantane is approved and marketed in Russia (Ladasten brand) and some post-Soviet countries. In the US, it is sold by underground research-chemical suppliers; legal status is ambiguous.

What does the research show about bromantane and cognition?

Russian studies report improvements in cognitive function, reaction time, and learning, but these trials often lack rigorous controls. Independent Western verification is lacking.

Is bromantane a stimulant?

Yes, bromantane is classified as a psychostimulant, similar in some respects to older stimulant medications, though its exact mechanism differs from amphetamine-class drugs.

How does bromantane feel compared to prescription stimulants?

Users report a gentler, more sustained effect than amphetamine-based stimulants, with less jitteriness but also possibly less potent wakefulness promotion.

References & further reading

R
u
s
s
i
a
n
c
l
i
n
i
c
a
l
l
i
t
e
r
a
t
u
r
e
(
L
a
d
a
s
t
e
n
t
r
i
a
l
s
)
;
p
o
s
t
-
S
o
v
i
e
t
n
e
u
r
o
p
s
y
c
h
o
l
o
g
y
r
e
s
e
a
r
c
h
;
a
n
i
m
a
l
d
o
p
a
m
i
n
e
-
m
o
d
u
l
a
t
i
o
n
s
t
u
d
i
e
s
;
l
i
m
i
t
e
d
W
e
s
t
e
r
n
p
s
y
c
h
o
p
h
a
r
m
a
c
o
l
o
g
y
s
o
u
r
c
e
s
.